drugset / Trial / NCT06705075

Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE

NCT06705075 ↗

Phase 2 Recruiting 80 enrolled Thomas Jefferson University
NaSingle-groupOpen-labelDiagnostic

Summary

This study goals are to determine the patterns of uterine fibroid vascularity pre and post UAE using CEUS resulting in an alternative to gadolinium-enhanced MRI that is less expensive, has less contra-indications and side effects, is real time, and noninvasive helping physicians to evaluate the result of UAE procedures. Also, this study will evaluate uterine fibroid pressures using SHAPE, comparing the results with normal myometrium tissue in order to determine its characteristics and tissue differences, which we believe will lead to the development of a new biomarker for the diagnosis and treatment of uterine fibroids.

Timeline

Start
2025-01-27
Primary completion
2026-08-31
Completion
2026-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Perfluten Unknown — —

Indications